TTP LabTech launches contract screening service
Instrumentation specialist TTP LabTech has introduced a contract screening service based on its Acumen microplate cytometer high content screening (HCS) technology.
Instrumentation specialist TTP LabTech has introduced a contract screening service based on its Acumen microplate cytometer high content screening (HCS) technology.
The service will provide clients with high-content data using cell-based assays for the investigation of various biological phenomena, including cell cycle, RNAi profiling, angiogenesis and signal pathway profiling.
Initially run from TTP LabTech's UK headquarters in Royston, Hertfordshire, the service is currently available in Standard and Full versions. The Standard offering includes the rapid scanning and analysis of pre-prepared experimental plates, while the Full service incorporates the entire process from cell culture, through compound/reagent treatment, to screening, analysis and data reporting, and can include assay development where required.
"In the past, prospective clients seeking direct access to high-content data have often asked us whether we can combine our in-house biology expertise with the latest lab tools to provide a complete package. We now feel that the time is right to introduce such a service to augment our existing product business," said Philip Blenkinsop, md of TTP LabTech.
